PharmaCielo Ltd (PCLOF)
0.1408
-0.03
(-16.43%)
USD |
OTCM |
May 31, 16:00
PharmaCielo Revenue (Quarterly): 0.2621M for Sept. 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.2621M |
| June 30, 2023 | 0.1186M |
| March 31, 2023 | 0.5813M |
| December 31, 2022 | 1.114M |
| September 30, 2022 | 0.364M |
| June 30, 2022 | 1.658M |
| March 31, 2022 | 0.9478M |
| December 31, 2021 | 0.2686M |
| September 30, 2021 | 0.3852M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.3631M |
| March 31, 2021 | 0.5328M |
| December 31, 2020 | 0.676M |
| September 30, 2020 | 0.0194M |
| June 30, 2020 | 0.8891M |
| March 31, 2020 | 0.3836M |
| December 31, 2019 | 0.4975M |
| September 30, 2019 | 0.0985M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0194M
Minimum
Sep 2020
1.658M
Maximum
Jun 2022
0.5388M
Average
0.3852M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | 1.173M |
| Venus Concept Inc | 17.48M |
| Juva Life Inc | 1.725M |
| Lucy Scientific Discovery Inc | 0.0097M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.057M |
| Total Expenses (Quarterly) | 1.999M |
| EPS Diluted (Quarterly) | -0.0149 |
| Enterprise Value | 35.50M |
| Gross Profit Margin (Quarterly) | -99.29% |
| Profit Margin (Quarterly) | -784.9% |
| Earnings Yield | -42.09% |
| Normalized Earnings Yield | -37.90 |